Feature

Expanding the Therapeutic Landscape in Wet Age-related Macular Degeneration

The role of TKIs and sustained‑release delivery

  • By

  • February 19, 2026

  • 6 min

Share

  • 1

    AMD is a leading cause of vision impairment over

  • 2

    Education and early interventions are critical.

  • 3

    Anti-VEGF therapy has been the standard treatment for two decades.

  • 4

    New therapies include multi-target inhibitors and sustained-release systems.

  • 5

    TKIs may improve long-term outcomes and reduce injection frequency.

Original Source(s)

Expanding the Therapeutic Landscape in Wet Age-related Macular Degeneration

The role of TKIs and sustained‑release delivery

  • February 19, 2026

  • 6 min

Related Content

Toward Better Management of Charles Bonnet Syndrome

Newly published guidance presents a practical guide to managing CBS in busy clinics

  • February 19, 2026

  • 3 min
Can Diabetic Eye Testing Be Simplified?

Three-test models matched nine-test battery in classifying disease stages

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk